Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2017 1
2018 1
2019 2
2020 3
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all The following term was ignored: :
Page 1
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Udell JA, et al. JAMA. 2013 Oct 23;310(16):1711-20. doi: 10.1001/jama.2013.279206. JAMA. 2013. PMID: 24150467
OBJECTIVES: To determine if influenza vaccination is associated with prevention of cardiovascular events. ...CONCLUSIONS AND RELEVANCE: In a meta-analysis of RCTs, the use of influenza vaccine was associated with a lower risk
OBJECTIVES: To determine if influenza vaccination is associated with prevention of cardiovascular events. ...CON …
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
Vardeny O, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, McGeer A, Talbot HK, Anand I, Bhatt DL, Cannon CP, DeMets D, Gaziano JM, Goodman SG, Nichol K, Tattersall MC, Temte JL, Wittes J, Yancy C, Claggett B, Chen Y, Mao L, Havighurst TC, Cooper LS, Solomon SD; INVESTED Committees and Investigators. Vardeny O, et al. JAMA. 2021 Jan 5;325(1):39-49. doi: 10.1001/jama.2020.23649. JAMA. 2021. PMID: 33275134 Free PMC article. Clinical Trial.
Higher influenza vaccine dose has been associated with reduced risk of influenza illness. OBJECTIVE: To evaluate whether high-dose trivalent influenza vaccine compared with standard-dose quadrivalent influenza vacc
Higher influenza vaccine dose has been associated with reduced risk of influenza illness. OBJECTIVE: To e …
Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
Ciszewski A. Ciszewski A. Vaccine. 2018 Jan 4;36(2):202-206. doi: 10.1016/j.vaccine.2017.11.078. Epub 2017 Dec 6. Vaccine. 2018. PMID: 29221893 Review.
Due to the wide interaction between the respiratory and the circulatory systems, influenza and pneumococcal vaccinations are recommended in the prevention and treatment of cardiovascular diseases. The review summarizes the results of recent studies and meta-a …
Due to the wide interaction between the respiratory and the circulatory systems, influenza and pneumococcal vaccinations are r …
Influenza vaccination: a 'shot' at INVESTing in cardiovascular health.
Bhatt AS, Vardeny O, Udell JA, Joseph J, Kim K, Solomon SD. Bhatt AS, et al. Eur Heart J. 2021 May 21;42(20):2015-2018. doi: 10.1093/eurheartj/ehab133. Eur Heart J. 2021. PMID: 33748833 Free PMC article.
The recently published results of the NHLBI-funded INfluenza Vaccine to Effectively Stop CardioThoracic Events and Decompensated (INVESTED) trial, a 5200 patient comparative effectiveness study of high-dose vs. standard-dose influenza vaccine
The recently published results of the NHLBI-funded INfluenza Vaccine to Effectively Stop CardioThoracic Events and Decompensat …
Influenza vaccination and major adverse vascular events in high-risk patients.
Johnstone J, Loeb M, Teo KK, Gao P, Dyal L, Liu L, Avezum A, Cardona-Munoz E, Sleight P, Fagard R, Yusuf S; Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET); Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators. Johnstone J, et al. Circulation. 2012 Jul 17;126(3):278-86. doi: 10.1161/CIRCULATIONAHA.111.071100. Epub 2012 Jun 19. Circulation. 2012. PMID: 22715472
The reduction in risk of noncardiovascular death associated with the influenza vaccine ranged from 73% to 79%. CONCLUSION: Although initial analyses suggest that influenza vaccination was associated with reduced risk of majo …
The reduction in risk of noncardiovascular death associated with the influenza vaccine ranged from 73% to 79%. C …
Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement.
Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos-Achirica M, Nasir K. Bhugra P, et al. J Am Heart Assoc. 2021 Aug 3;10(15):e019671. doi: 10.1161/JAHA.120.019671. Epub 2021 Jul 28. J Am Heart Assoc. 2021. PMID: 34315229 Free PMC article. Review.
Influenza infection is associated with an increased risk of cardiovascular events (myocardial infarction, stroke, and heart failure exacerbation) and mortality, and all-cause mortality in patients with CVD. ...Hence, many international guideline
Influenza infection is associated with an increased risk of cardiovascular events (myocardial infarction, stroke
Effect of Influenza on Outcomes in Patients With Heart Failure.
Panhwar MS, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, Ginwalla M. Panhwar MS, et al. JACC Heart Fail. 2019 Feb;7(2):112-117. doi: 10.1016/j.jchf.2018.10.011. Epub 2019 Jan 2. JACC Heart Fail. 2019. PMID: 30611718 Free article.
BACKGROUND: Patients with HF may be at increased risk of morbidity and mortality from influenza infection. ...Our results emphasize the need for efforts to mitigate the incidence of influenza, specifically in this high-risk patient
BACKGROUND: Patients with HF may be at increased risk of morbidity and mortality from influenza infection. ...Our resul …
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
Grandhi GR, Mszar R, Vahidy F, Valero-Elizondo J, Blankstein R, Blaha MJ, Virani SS, Andrieni JD, Omer SB, Nasir K. Grandhi GR, et al. JAMA Cardiol. 2021 Jan 1;6(1):87-91. doi: 10.1001/jamacardio.2020.3978. JAMA Cardiol. 2021. PMID: 32902562 Free PMC article.
A stepwise increase was found in the prevalence and odds of lacking influenza vaccination among individuals with increase in high-risk characteristics. ...Focused public health initiatives are needed to increase access to influenza vaccinatio
A stepwise increase was found in the prevalence and odds of lacking influenza vaccination among individuals with increase in …
Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
Ilic I, Zdravkovic M, Timcic S, Stojanovic DU, Bojic M, Loncar G. Ilic I, et al. Int J Infect Dis. 2021 Feb;103:188-193. doi: 10.1016/j.ijid.2020.11.156. Epub 2020 Nov 19. Int J Infect Dis. 2021. PMID: 33220441 Free PMC article.
OBJECTIVES: The pandemic of coronavirus associated disease (COVID-19) placed the health care workers at high risk. ...Seventy-five of 107 (70.1%) received seasonal influenza vaccine. Pneumonia with CT features of GGO and consolidation occurred i …
OBJECTIVES: The pandemic of coronavirus associated disease (COVID-19) placed the health care workers at high risk. ...S …
Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination.
Behrouzi B, Udell JA. Behrouzi B, et al. Curr Atheroscler Rep. 2021 Oct 21;23(12):78. doi: 10.1007/s11883-021-00973-w. Curr Atheroscler Rep. 2021. PMID: 34671861 Free PMC article. Review.
There are four large cardiovascular outcome trials assessing the cardioprotective effects of different influenza vaccine strategies. Among these, the INVESTED study showed there is no significant difference between the high-dose trivalent and st …
There are four large cardiovascular outcome trials assessing the cardioprotective effects of different influenza vac
15 results